News &amp; Updates

Children maintaining a sustained adherence rate of at least 85 percent to daily growth hormone therapy see a clinically meaningful improvement in growth over 2 years, as shown in a retrospective study.

Sustained adherence to growth hormone therapy boosts growth outcomes in children

Immunotherapy modestly improves response rates in HR+ breast cancer

Patients with HR+/HER2‒ breast cancer treated with immunotherapy show modest improvements in complete response rates, reports a study.

Immunotherapy modestly improves response rates in HR+ breast cancer

One-time gene replacement therapy improves motor function in SMA patients

04 Jun 2026 by

Intrathecal onasemnogene abeparvovec (OAV101 IT), a one-time gene transfer therapy, significantly improves motor function in treatment-naïve patients with spinal muscular atrophy (SMA), as shown by the period 1 results of the phase III STEER study.

One-time gene replacement therapy improves motor function in SMA patients

Recent COVID vaccination may reduce transmission

Recent COVID-19 vaccination has been linked to a reduced risk of SARS-CoV-2 transmission in a prospective, case-ascertained household transmission study.

Recent COVID vaccination may reduce transmission

Tirzepatide lowers risk of diabetic retinopathy, complications

Treatment with tirzepatide, compared with lifestyle intervention alone, helps prevent the incidence of new or progressive diabetic retinopathy (DR) and its complications among patients with diabetes and overweight or obesity, suggests a study.

Tirzepatide lowers risk of diabetic retinopathy, complications

03 Jun 2026

GLP-1 RA use may improve breast cancer outcomes in patients with metabolic conditions

In breast cancer patients with obesity or type 2 diabetes (T2D), the use of a glucagon-like peptide-1 receptor agonist (GLP-1 RA) appears to exert favourable effects on mortality and recurrence, according to a retrospective study.

GLP-1 RA use may improve breast cancer outcomes in patients with metabolic conditions

New-found anti-ageing effects of GLP-1 RAs can potentially improve severe stroke recovery

Researchers from the Chinese University of Hong Kong (CUHK) and the Gerald Choa Neuroscience Institute (GCNI) have achieved a breakthrough “bench-to-bedside” advancement, translating discovery of multi-omic ageing counteraction with glucagon-like peptide-1 (GLP-1) receptor agonism into a potential new treatment strategy for stroke.

New-found anti-ageing effects of GLP-1 RAs can potentially improve severe stroke recovery

Award-winning world-first nasal spray as prehospital emergency aid for ischaemic stroke

Researchers from the University of Hong Kong (HKU) have developed the world’s first NanoPowder nasal spray for use as prehospital emergency treatment at the onset of an ischaemic stroke, which can potentially reduce brain damage by >80 percent and substantially increase stroke survival rates and neurological recovery, representing a significant advancement in stroke management globally.

Award-winning world-first nasal spray as prehospital emergency aid for ischaemic stroke